As of May 2022 Novocure has a market cap of $7.40 Billion. This makes Novocure the world's 1756th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $6.82 B | -12.46% |
2021 | $7.79 B | -55.75% |
2020 | $17.61 B | 110.02% |
2019 | $8.38 B | 168.64% |
2018 | $3.12 B | 72.96% |
2017 | $1.80 B | 164.99% |
2016 | $0.68 B | -63.63% |
2015 | $1.87 B |
On May 18th, 2022 the market cap of Novocure was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Organovo ONVO | $0.02 B | -99.69% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | $0.05 B | -99.20% | ๐ฌ๐ง UK |
![]() Novavax NVAX | $4.70 B | -36.39% | ๐บ๐ธ USA |
![]() Novocure
NVCR | $7.40 B | 0.00% | Jersey |